Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 16,557	$ 11,231
Accounts receivable, net	13,973	15,958
Inventory	6,493	18,515
Prepaid expenses and other current assets	2,921	5,558
Total current assets	39,944	51,262
Property and equipment, net	377	1,108
Right of use assets, net	937	2,260
Intangible assets, net	2,210	2,279
Other assets	655	1,195
Total assets	44,123	58,104
Current liabilities:
Accounts payable	13,679	30,432
Accrued and other expenses	15,051	19,984
Current portion of deferred revenues	1,166	1,148
Line of credit	9,250	4,685
Current portion of long-term debt	5,944	10,353
Total current liabilities	45,090	66,602
Noncurrent lease liability	22	1,162
Common stock warrant liabilities	27,781	724
Other long-term liabilities	906	251
Total liabilities	73,799	68,739
Commitments and contingencies (Note 7)
Series A convertible preferred stock, 0.0001 par value, 10,741,071 shares authorized as of December 31, 2023 and December 31, 2022; 28,628 and 0 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively (liquidation preference of $28,628)	7,855	0
Stockholders’ deficit:
Common stock, $0.0001 par value, 107,142,857 shares authorized as of December 31, 2023 and December 31, 2022; 8,797,456 and 8,242,009 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively.	1	1
Additional paid-in capital	218,127	212,122
Accumulated deficit	(255,659)	(222,758)
Total stockholders’ deficit	(37,531)	(10,635)
Total liabilities, convertible preferred stock, and stockholders’ deficit	$ 44,123	$ 58,104
Common stock, shares authorized (in shares)	107,142,857